Phase II study of Baker's antifol in advanced colorectal cancer.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013997:Time Factors; D014227:Triazines / Q000009:adverse effects / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D014227:Triazines; C012071:triazinate